KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Current Leases: 2019-2025

Historic Current Leases for Twist Bioscience (TWST) over the last 6 years, with Sep 2025 value amounting to $13.8 million.

  • Twist Bioscience's Current Leases fell 6.64% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year decrease of 6.64%. This contributed to the annual value of $13.8 million for FY2025, which is 6.64% down from last year.
  • According to the latest figures from Q3 2025, Twist Bioscience's Current Leases is $13.8 million, which was down 10.83% from $15.5 million recorded in Q2 2025.
  • Over the past 5 years, Twist Bioscience's Current Leases peaked at $15.5 million during Q2 2025, and registered a low of $6.5 million during Q1 2021.
  • Its 3-year average for Current Leases is $14.5 million, with a median of $14.8 million in 2024.
  • Per our database at Business Quant, Twist Bioscience's Current Leases decreased by 16.24% in 2021 and then soared by 117.47% in 2022.
  • Quarterly analysis of 5 years shows Twist Bioscience's Current Leases stood at $12.7 million in 2021, then increased by 12.16% to $14.2 million in 2022, then increased by 4.08% to $14.8 million in 2023, then increased by 1.50% to $15.0 million in 2024, then fell by 6.64% to $13.8 million in 2025.
  • Its last three reported values are $13.8 million in Q3 2025, $15.5 million for Q2 2025, and $15.2 million during Q1 2025.